Tsukioka K, Makino S, Miyamoto T, Mikawa H, Tomioka H, Ito K, Adachi M, Nishikawa K, Baba M, Takahashi T
Department of Internal Medicine, National Nishi-Niigata Hospital.
Arerugi. 1995 Apr;44(4):513-9.
A questionnaire on the evaluation of "The Guidelines on Diagnosis and Management of Asthma" edited by the Japanese Society of Allergology in 1993 was sent to 586 physicians consisting of specialists authorized by the Japanese Society of Allergology and the board members of this Society, who treated patients with bronchial asthma. Of total 306 (52.2%) who responded, 177 (57.8%) answered the questions on adult asthma only, 65 (21.2%) on childhood asthma only and 52 (17.9%) on both adult and childhood asthma. In total, we had 229 respondents on adult asthma and 117 on childhood asthma. As a result, on drug therapy for chronic asthma, it was pointed out that the use of oral anti-allergics, oral steroids and inhaled beta-stimulants was excessive whereas the use of DSCG, inhaled steroids and long acting theophylline was slightly insufficient in both adults and children. On the management of acute episodes, the excessive use of beta-stimulants (inhaled, oral and injections) and the lack of the use of parenteral steroids and oxygen inhalation were pointed out in adults. The lack of oxygen inhalation also got a higher percent in children. Nevertheless, the guidelines were found to be highly regarded as a whole: "Very good" was 6.1% in adults (6.8% in children). "Appropriate" 38.0% (33.3%), "Almost appropriate" 52.0% (52.1%) and "Inappropriate" 3.9% (3.4%).
一份关于日本变态反应学会1993年编辑的《支气管哮喘诊断和管理指南》评估的调查问卷被寄给了586名医生，这些医生包括日本变态反应学会授权的专家以及该学会的理事会成员，他们都治疗支气管哮喘患者。在总共306名（52.2%）回复者中，177名（57.8%）仅回答了关于成人哮喘的问题，65名（21.2%）仅回答了关于儿童哮喘的问题，52名（17.9%）既回答了成人哮喘问题也回答了儿童哮喘问题。总共，我们有229名成人哮喘回复者和117名儿童哮喘回复者。结果显示，在慢性哮喘的药物治疗方面，指出成人和儿童口服抗过敏药、口服类固醇和吸入型β受体激动剂的使用过度，而色甘酸钠、吸入型类固醇和长效茶碱的使用略显不足。在急性发作的管理方面，指出成人过度使用β受体激动剂（吸入、口服和注射），且缺乏使用胃肠外类固醇和吸氧。儿童吸氧不足的比例也较高。然而，该指南总体上被高度评价：成人中“非常好”占6.1%（儿童中占6.8%）。“合适”占38.0%（33.3%），“大致合适”占52.0%（52.1%），“不合适”占3.9%（3.4%）。
